Shannon Puhalla

ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner et al. · Clinical Cancer Research · 2020 · 230 citations

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial

Stephen Johnston, Shannon Puhalla, Duncan Wheatley et al. · Journal of Clinical Oncology · 2018 · 224 citations · Full text

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Heather Han, Véronique Dièras, Mark E. Robson et al. · Annals of Oncology · 2017 · 201 citations · Full text

Carboplatin/paclitaxel Versus Placebo, Breast Oncology, Recurrent/metastatic Breast Cancer +9

Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic HER2-Positive Breast Cancer

Sharon Wilks, Shannon Puhalla, Joyce O’Shaughnessy et al. · Clinical Breast Cancer · 2014 · 68 citations · Full text

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

Carey K. Anders, Allison M. Deal, Vandana G. Abramson et al. · Breast Cancer Research and Treatment · 2014 · 65 citations · Full text

Breast Oncology, Oncology, Chemoprevention Strategy +13